Brief: ImmuCell Corporation Q1 EPS USD 0.21
14/05/2026 21:05
May 14 (Reuters) - ImmuCell Corporation Q1 operating expenses USD 2.688 million. Q1 pretax profit USD 1.954 million Q1 net income USD 1.942 million
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year